Acute kidney injury after placement of an antibiotic-impregnated cement spacer during revision total knee arthroplasty.

Menge TJ, Koethe JR, Jenkins CA, Wright PW, Shinar AA, Miller GG, Holt GE
J Arthroplasty. 2012 27 (6): 1221-7.e1-2

PMID: 22321301 · DOI:10.1016/j.arth.2011.12.005

We performed a retrospective cohort study of 84 patients to determine the incidence and predictors of acute kidney injury after antibiotic-impregnated cement spacer (ACS) placement for infected total knee arthroplasties. Acute kidney injury was defined as a more than 50% rise in serum creatinine from a preoperative baseline to a level greater than 1.4 mg/dL within 90 days postoperatively. Total incidence was 17% (n = 14; 95% confidence interval [CI], 10%-26%), and acute kidney injury was significantly associated with ACS tobramycin dose as both a dichotomous variable (>4.8 g; odds ratio, 5.87; 95% CI, 1.43-24.19; P = .01) and linear variable (odds ratio, 1.24 for every 1-g increase; 95% CI, 1.00-1.52; P = .049). Routine monitoring of serum creatinine and measurement of serum aminoglycoside levels in response to a threshold creatinine rise may be warranted after the placement of an aminoglycoside-containing ACS.

Copyright © 2012 Elsevier Inc. All rights reserved.

MeSH Terms (19)

Acute Kidney Injury Aged Aminoglycosides Anti-Bacterial Agents Arthroplasty, Replacement, Knee Bone Cements Cohort Studies Creatinine Female Humans Incidence Kidney Knee Prosthesis Male Middle Aged Prosthesis-Related Infections Reoperation Retrospective Studies Tobramycin

Connections (1)

This publication is referenced by other Labnodes entities: